Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.44
Delayed Data
As of Dec 02
 -0.0125 / -2.76%
Today’s Change
0.35
Today|||52-Week Range
0.75
-35.53%
Year-to-Date
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
Dec 02 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close0.45
Today’s open0.46
Day’s range0.42 - 0.47
Volume832,967
Average volume (3 months)152,246
Market cap$19.5M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)-24.62%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-44.00%
P/E ratio1.2
Price/Sales1.73
Price/Book1.08

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.5M
Annual profit (last year)$21.6M
Net profit margin123.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Principal Financial &
Accounting Officer
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts


Search for Jobs